Learning from antibacterial resistance to control drug-resistant Aspergillus fumigatus (ABR2AFR)en (ABR2AFR)
The fungus Aspergillus fumigatus causes respiratory diseases including invasive aspergillosis (IA). Medical azoles play an important role in the treatment of IA and other Aspergillus diseases. The treatment of Aspergillus diseases is increasingly complicated by azole resistance, which is mainly caused by azole fungicide presence in the environment. The resistance problem is complex and affects various public and private stakeholders. Investigations intothis problem are underway both nationally (Health Council) and internationally (EU Commission), which will lead to advisory reports ultimately in Q4 of 2024.
Aim
The aim of our project is to use the results of these studies to organise an international stakeholder meeting in which all relevant stakeholders (governments, scientists, users and producers) participate. The objective is to apply 6 determinants of successful control of bacterial resistance to resistance in A. fumigatus and develop an AFR road map.